Elucidating the beneficial impact of exercise on chronic obstructive pulmonary disease and its comorbidities: Integrating proteomic and immunological insights
Authors:
- 24 September 2024
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 181 (24) , 5133-5150
Abstract
Background and Purpose: Physical activity is an effective therapeutic protocol for treating chronic obstructive pulmonary disease (COPD). However, the mechanisms underlying the benefits of physical activity in COPD are not fully elucidated.Experimental Approach: In a mouse model of COPD, analysis of biological markers and lung proteomics identified the molecular pathways through which exercise ameliorates COPD.Key Results: Exercise improved pulmonary function, emphysema, small airway disease, pulmonary inflammation, glucose metabolic dysregulation, and insulin resistance in COPD mice. Proteomic analysis revealed 430 differentially expressed proteins (DEPs) between the COPD and COPD + Exercise (COPD + Ex) groups. GO analysis indicated that the enriched pathways were predominantly related to the immune response, inflammatory processes, insulin secretion, and glucose metabolic processes. GO analysis revealed IL‐33 as a crucial target for the exercise‐related amelioration of COPD. KEGG analysis showed that DEPs were significantly enriched in primary immunodeficiency, the intestinal immune network for IgA production, and the NF‐κB signalling pathway. Exercise inhibited NF‐κB activation by suppressing the CD14/TLR4/MyD88 and TNF‐α/TNF‐R1/TRAF2/5 pathways in COPD mice. Exercise inhibited expression of BCR, IgM, IgD, IgG, IgE, and IgA by suppressing B‐cell receptor signalling. Exercise attenuated glucose metabolic dysregulation and insulin resistance through the suppression of proinflammatory mediators, including MHC I, MHC II, TNF‐α, IFN‐γ, and IL‐1β, while concurrently increasing insulin expression. The qRT‐PCR results were consistent with the proteomic results.Conclusion and Implications: In a mouse model, exercise improved COPD and its metabolic comorbidities through immune system regulation and inflammation suppression, offering insights into potential therapeutic targets.Keywords
Funding Information
- Social Science Planning Project of Shandong Province (18CTYJ02, 23CTYJ05)
This publication has 75 references indexed in Scilit:
- Effectiveness of a Long-term Home-Based Exercise Training Program in Patients With COPD After Pulmonary RehabilitationChest, 2022
- Objectively Measured Physical Activity as a COPD Clinical Trial OutcomeChest, 2021
- Nuclear factor-kappa B and its role in inflammatory lung diseaseChemico-Biological Interactions, 2021
- Aerobic exercise ameliorates particulate matter-induced lung injury in aging ratsEnvironmental Pollution, 2021
- Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD)Cochrane Database of Systematic Reviews, 2020
- Oxidative, inflammatory, genetic, and epigenetic biomarkers associated with chronic obstructive pulmonary disorderJournal of Cellular Physiology, 2018
- 12,13-diHOME: An Exercise-Induced Lipokine that Increases Skeletal Muscle Fatty Acid UptakeCell Metabolism, 2018
- Impact of Endurance Exercise Training in the Fasted State on Muscle Biochemistry and Metabolism in Healthy Subjects: Can These Effects be of Particular Clinical Benefit to Type 2 Diabetes Mellitus and Insulin-Resistant Patients?Sports Medicine, 2016
- Exercise resistance across the prediabetes phenotypes: Impact on insulin sensitivity and substrate metabolismReviews in Endocrine and Metabolic Disorders, 2016
- IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated CytokinesImmunity, 2005